Subsequently, with the discovery of the association between mTOR signaling and cancer, FDA-approved mTOR inhibitors have been employed in clinical trials for cancer treatment, while various other mTOR inhibiting molecules are currently under development [28]. The gene discussed is MTOR; the disease is cancer.